Main Article Content
Objective: The applicability in reverse genetics studies, animal model experiments and also in curing diseases caused by viruses like HIV makes the CRISPR-Cas9 system a highly desirable technique with the ability to achieve quick plausible outcomes. The bacterial cells chop up the viral genome. And its search of these pieces of spacer DNA. The spacer DNA is nothing but pieces of the different viral genome. That had infected the cell previously. So each time of bacteriophage infects the cell take it pieces and search of spacer DNA. The interference is between the specific Cas protein and RNA Sequence has going to be merged together. The Crispr system would be somehow like adopted immune system in human. it would kind of memory to prevent this same bacteriophage for infecting the cell other time.
Purpose (Hypothesis): This article main purpose to describe the Genome editing enabled by the development of tools to make precise, targeted changes to the genome of living cells.
Methods (Technique): CRISPR-Cas9.
Conclusion: The CRISPR-Cas9 is the key to genetic revaluation era. This tool is very useful for studying the genetic code. at finally in this review both in modelling and the CRISPR/Cas9 system have emerged as a feasible tool to achieve what has seemed impossible for decades.
Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007;315:1709–1712. [Cross Ref] [PubMed].
Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat. Biotechnol. 2015;33:538–542. [Cross Ref] [PubMed].
Nunez JK, LeeASY, EngelmanA and Doudna JA. Integrase-mediated spacer acquisition during CRISPR-Cas Adaptive Immunity NATURE. 2015;519: 193–8.
Van der Oost J, Westra ER, Jackson RN, Wiedenheft B. Unravelling the structural and mechanistic basis of CRISPRCas systems Nat. Rev. Microbiol. 2014;12:479–92.
Kñez Nu J, Harrington LB, Kranzusch PJ, Engelman AN, Doudna JA. Foreign DNA Capture during CRISPR-Cas Adaptive Immunity Nature. 2015;527:535–8.
Arslan Z, Hermanns V, Wurm R, Wagner R, Pul Ü. Detection and characterization of spacer integration intermediates in type IE CRISPR-Cas system Nucl. Acids Res. 2014;42:7884–93.
Zhang Y, Heidrich N, Ampattu BJ, Gunderson CW, Seifert HS, Schoen C, Vogel J, Sontheimer EJ. Processing independent CRISPR RNAs limit natural transformation in Neisseria meningitidis Mol. Cell. 2013;50:488–503.
Deng L, Kenchappa CS, Peng X, She Q, Garrett RA. Modulation of CRISPR locus transcription by the repeatbinding protein Cbp1 in Sulfolobus Nucl. Acids Res. 2011;40:2470–80.
Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert M R, Vogel J, Charpentier E. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III Nature. 2011; 471:602–7.
Zetsche B, et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system Cell. 2015;163:759–71.
Chylinski K, Le Rhun A, Charpentier E. The tracr RNA and Cas9 families of type II CRISPR-Cas immunity systems, RNA Biol. 2013;10(5):726e737.
Richter C, Dy RL, McKenzie RE, Watson BN, Taylor C, Chang JT, McNeil MB, Staals RH, Fineran PC. Priming in the Type I-F CRISPR-Cas system triggers strandindependent spacer acquisition, bi-directionally from the primed protospacer, Nucleic Acids Res. 2014;42(13): 8516e8526.
Alex Reis, Bitesize. CRISPR/Cas9 & targeted genome editing: New era in molecular biology, NEB expressions Issue I; 2014.